339 related articles for article (PubMed ID: 19751941)
1. Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide.
Michotte A; Chaskis C; Sadones J; Veld PI; Neyns B
J Neurol Sci; 2009 Dec; 287(1-2):267-70. PubMed ID: 19751941
[TBL] [Abstract][Full Text] [Related]
2. Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.
Brandes AA; Tosoni A; Cavallo G; Reni M; Franceschi E; Bonaldi L; Bertorelle R; Gardiman M; Ghimenton C; Iuzzolino P; Pession A; Blatt V; Ermani M;
J Clin Oncol; 2006 Oct; 24(29):4746-53. PubMed ID: 16954518
[TBL] [Abstract][Full Text] [Related]
3. Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide.
Wang F; Qiao G; Lou X
J Neurooncol; 2011 Aug; 104(1):387-94. PubMed ID: 21190059
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study.
Ahluwalia MS; Xie H; Dahiya S; Hashemi-Sadraei N; Schiff D; Fisher PG; Chamberlain MC; Pannullo S; Newton HB; Brewer C; Wood L; Prayson R; Elson P; Peereboom DM
J Neurooncol; 2015 Mar; 122(1):111-9. PubMed ID: 25534576
[TBL] [Abstract][Full Text] [Related]
5. Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression.
Levin N; Lavon I; Zelikovitsh B; Fuchs D; Bokstein F; Fellig Y; Siegal T
Cancer; 2006 Apr; 106(8):1759-65. PubMed ID: 16541434
[TBL] [Abstract][Full Text] [Related]
6. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.
Kouwenhoven MC; Kros JM; French PJ; Biemond-ter Stege EM; Graveland WJ; Taphoorn MJ; Brandes AA; van den Bent MJ
Eur J Cancer; 2006 Oct; 42(15):2499-503. PubMed ID: 16914310
[TBL] [Abstract][Full Text] [Related]
7. Paediatric diffuse leptomeningeal tumor with glial and neuronal differentiation harbouring chromosome 1p/19q co-deletion and H3.3 K27M mutation: unusual molecular profile and its therapeutic implications.
Nambirajan A; Suri V; Kedia S; Goyal K; Malgulwar PB; Khanna G; Panda PK; Gulati S; Garg A; Sharma MC
Brain Tumor Pathol; 2018 Jul; 35(3):186-191. PubMed ID: 30030640
[TBL] [Abstract][Full Text] [Related]
8. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Kaloshi G; Benouaich-Amiel A; Diakite F; Taillibert S; Lejeune J; Laigle-Donadey F; Renard MA; Iraqi W; Idbaih A; Paris S; Capelle L; Duffau H; Cornu P; Simon JM; Mokhtari K; Polivka M; Omuro A; Carpentier A; Sanson M; Delattre JY; Hoang-Xuan K
Neurology; 2007 May; 68(21):1831-6. PubMed ID: 17515545
[TBL] [Abstract][Full Text] [Related]
10. Primary diffuse leptomeningeal oligodendroglioma. Case report.
Chen R; Macdonald DR; Ramsay DA
J Neurosurg; 1995 Oct; 83(4):724-8. PubMed ID: 7674024
[TBL] [Abstract][Full Text] [Related]
11. Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child.
Rossi S; Rodriguez FJ; Mota RA; Dei Tos AP; Di Paola F; Bendini M; Agostini S; Longatti P; Jenkins RB; Giannini C
Acta Neuropathol; 2009 Oct; 118(4):575-7. PubMed ID: 19562354
[No Abstract] [Full Text] [Related]
12. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.
Rodriguez FJ; Perry A; Rosenblum MK; Krawitz S; Cohen KJ; Lin D; Mosier S; Lin MT; Eberhart CG; Burger PC
Acta Neuropathol; 2012 Nov; 124(5):627-41. PubMed ID: 22941225
[TBL] [Abstract][Full Text] [Related]
13. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment.
Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma.
Mikkelsen T; Doyle T; Anderson J; Margolis J; Paleologos N; Gutierrez J; Croteau D; Hasselbach L; Avedissian R; Schultz L
J Neurooncol; 2009 Mar; 92(1):57-63. PubMed ID: 19011763
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.
Hoang-Xuan K; Capelle L; Kujas M; Taillibert S; Duffau H; Lejeune J; Polivka M; Crinière E; Marie Y; Mokhtari K; Carpentier AF; Laigle F; Simon JM; Cornu P; Broët P; Sanson M; Delattre JY
J Clin Oncol; 2004 Aug; 22(15):3133-8. PubMed ID: 15284265
[TBL] [Abstract][Full Text] [Related]
16. Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. Case report.
Bourne TD; Mandell JW; Matsumoto JA; Jane JA; Lopes MB
J Neurosurg; 2006 Dec; 105(6 Suppl):465-9. PubMed ID: 17184079
[TBL] [Abstract][Full Text] [Related]
17. Diffuse leptomeningeal neuroepithelial tumor: 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry.
Schniederjan MJ; Alghamdi S; Castellano-Sanchez A; Mazewski C; Brahma B; Brat DJ; Brathwaite CD; Janss AJ
Am J Surg Pathol; 2013 May; 37(5):763-71. PubMed ID: 23588371
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal dissemination of a pediatric neoplasm with 1p19q deletion showing mixed immunohistochemical features of an oligodendroglioma and neurocytoma.
Rhiew RB; Manjila S; Lozen A; Guthikonda M; Sood S; Kupsky WJ
Acta Neurochir (Wien); 2010 Aug; 152(8):1425-9. PubMed ID: 20446099
[TBL] [Abstract][Full Text] [Related]
19. Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature.
Sorge C; Li R; Singh S; Reddy AT; Solomon DA; Perry A; Friedman GK
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28696020
[TBL] [Abstract][Full Text] [Related]
20. Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case Report.
Strickland BA; Cachia D; Jalali A; Cykowski MD; Penas-Prado M; Langford LA; Li J; Shah K; Weinberg JS
Neurosurgery; 2016 Mar; 78(3):E466-73. PubMed ID: 26352098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
